Rchr
J-GLOBAL ID：201801012233304642   Update date: Feb. 01, 2024

Eisuke Hida

ヒダ エイスケ | Eisuke Hida
Affiliation and department：
大阪大学 医学系研究科

About 大阪大学 医学系研究科


Job title： 特任教授(常勤)
Homepage URL  (1)： http://www2.med.osaka-u.ac.jp/biostat/grouptop
Research field  (1)： Statistical science
Research theme for competitive and other funds  (4)：
  • 2009 - 2012 Effects of new dietary lifestyle education program for metabolic syndrome patients based on randomized control trials
  • 2009 - 2011 A study of statistical science on health and culture : a cross-national study on dynamics of social disparity and life
  • 2008 - 2010 The effects of lifestyle modification on metabolic syndrome : a meta-analysis
  • 2008 - 2010 Statistical research on the design of clinical trials where the quantitative balance of benefits and risks is taken into account.
Papers (59)：
  • Masayuki Nakamori, Daisaku Nakatani, Tomoharu Sato, Yuhei Hasuike, Seiko Kon, Toshio Saito, Harumasa Nakamura, Masanori P. Takahashi, Eisuke Hida, Hirofumi Komaki, et al. Erythromycin for myotonic dystrophy type 1: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. eClinicalMedicine. 2024
  • Masaya Sato, Masatoshi Akamatsu, Toshihide Shima, Tadashi Ikegami, Mikio Yanase, Shintaro Mikami, Jun Imamura, Takuma Nakatsuka, Ryosuke Tateishi, Naoko Yamauchi, et al. Impact of a Novel Digital Therapeutics System on Nonalcoholic Steatohepatitis: The NASH App Clinical Trial. The American journal of gastroenterology. 2023. 118. 8. 1365-1372
  • Takami Ishizuka, Hirofumi Komaki, Yasuko Asahina, Harumasa Nakamura, Norio Motohashi, Eri Takeshita, Yuko Shimizu-Motohashi, Akihiko Ishiyama, Chihiro Yonee, Shinsuke Maruyama, et al. Systemic administration of the antisense oligonucleotide NS-089/NCNP-02 for skipping of exon 44 in patients with Duchenne muscular dystrophy: Study protocol for a phase I/II clinical trial. Neuropsychopharmacology reports. 2023. 43. 2. 277-286
  • Taigo Kato, Nobuaki Matsubara, Masaki Shiota, Masatoshi Eto, Takahiro Osawa, Takashige Abe, Nobuo Shinohara, Yota Yasumizu, Nobuyuki Tanaka, Mototsugu Oya, et al. IMAGENE trial: multicenter, proof-of-concept, phase II study evaluating the efficacy and safety of combination therapy of niraparib with PD-1 inhibitor in solid cancer patients with homologous recombination repair genes mutation. BMC cancer. 2022. 22. 1. 1292-1292
  • Masaki Hayama, Yohei Maeda, Takashi Shikina, Shun Tatehara, Go Inokuchi, Jeffrey B Hoag, Tomoharu Sato, Sho Obata, Ayaka Nakatani, Yuta Amano, et al. Validation of epistaxis severity score for hereditary hemorrhagic telangiectasia in Japan. Auris, nasus, larynx. 2022. 49. 3. 415-420
ｍore...
MISC (13)：
ｍore...
Books (3)：
  • 臨床試験の事典
    朝倉書店 2023 ISBN:9784254322644
  • 社会調査事典
    丸善出版 2014 ISBN:4621087312
  • 医学統計学の事典
    朝倉書店 2010 ISBN:9784254121766
Education (3)：
  • 1999 - 2002 University of Tsukuba
  • 1997 - 1999 University of Tsukuba Graduate School, Division of Mathematics
  • 1993 - 1997 University of Tsukuba Graduate School, Division of Mathematics
Professional career (1)：
  • 博士(理学) (筑波大学)
Work history (8)：
  • 2018/10/01 - 現在 Osaka University Graduate School of Medicine Specially Appointed Professor
  • 2017/07/01 - 現在 Osaka University Osaka University Hospital
  • 2017/07/01 - 2018/09/30 Osaka University Graduate School of Medicine Associate Professor
  • 2014/04 - 2017/06 広島大学病院総合医療研究推進センター
  • 2011/01 - 2014/03 独立行政法人 医薬品医療機器総合機構
Show all
Association Membership(s) (4)：
The International Society for Clinical Biostatistics ,  The International Biometric Society ,  日本統計学会 ,  日本計量生物学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM